Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 821 results for "mylan"

Human medicines European public assessment report (EPAR): Ra...

This is a summary of the European public assessment report (EPAR) for Rasagiline Mylan. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical ... European Medicines Agency, 20 hours ago

Pharmaceutical Newsletter - April 25 to 29, 2016

Top News Delhi HC allows Biocon, Mylan to continue sale of Cancer drugs The Delhi High Court has allowed Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd to continue manufacturing and marketing their breast cancer drug under brand names CANMAb and ...
 India Infoline1 day ago Biocon, Mylan to challenge Delhi HC interim order on breast cancer drug  Livemint.com2 days ago BIOCON : Delhi High Court permits Biocon, Mylan to carry on trade of Cancer drugs  4 Traders2 days ago PTI - HC-DRUGS - HC allows Biocon, Mylan to continue manufacturing cancer drugs  Namibia Press Agency3 days ago

Mylan (MYL) Q1 Earnings: What's in the Cards for the Stock?

By Zacks Equity Research 49 minutes ago Mylan N.V. MYL is scheduled to report first-quarter 2016 results on May 3, before the opening bell. Last quarter, the company recorded a negative earnings surprise of 2.40%. Let's see ...
 Yahoo! Finance1 day ago Mylan (MYL) Stock Pressured by Perrigo Profit Warning  TheStreet.com4 days ago
Bidness Etc

Has Papa Left Perrigo Company Back in Mylan Claws?

Perrigo Company plc ( NYSE:PRGO ) was betrayed by its decade-old CEO, Joseph Papa, on Monday when he chose to jump ship during one of the company's most trying times. The same day, the maker of store-brand drugs issued a reduced outlook for 2016 and ...
 Bidness Etc3 days ago Goldman Selling Perrigo, Prefers Mylan And Teva  Benzinga.com4 days ago Valeant Names Perrigo's Papa as CEO to Lead Turnaround  Bloomberg4 days ago As Its CEO Leaves to for Valeant, Perrigo Continues to Struggle -- 2nd Update  Morningstar.com4 days ago
Times of India

Biocon, Mylan likely to appeal Delhi HC ruling on Roche's cancer drug trastuzumab

MUMBAI: Makers of biosimilar drugs are unhappy with a Delhi High Court ruling that imposed certain conditions on Biocon and Mylan to sell copies of Roche's blockbuster biotech-based breast cancer drug, trastuzumab. The April 25 order, which raised ...
 Economic Times2 days ago Biocon, Mylan fume over HC rap on selling copies of Roche's drug  Economic Times2 days ago Delhi High Court order on copies of Roche's cancer drug draws flak  Economic Times2 days ago

Tue: Perrigo free fall pulls TASE down

Perrigo plunged and fellow drugmakers Teva and Mylan were sharply down as most Tel Aviv 25 shares rose. The Tel Aviv Stock Exchange (TASE) fell today. The Tel Aviv 25 Index fell 1.37% to 1,463.89 points, the Tel Aviv 100 Index fell 1.63%, to ...
 Globes3 days ago Tue: TASE rally extends to fifth straight session  Globes1 week ago Sun: TASE rally continues led by Delek  Globes1 week ago

Mylan focuses on new generation solutions from Hackathon events to offset healthcare challenges

Mylan is set for focusing on a new generation of solutions capable of delivering better health for the people. With this aim, it recently concluded a dual health Hackathon event at Pittsburgh, US and Bengaluru providing a platform for professionals ...
 PharmaBiz2 days ago

Interim order on Roche’s breast cancer drug sends ‘bio-similar versions’ into spin

Court disallows Biocon, Mylan and Reliance Lifesciences to claim their drug as bio-similar Mumbai, April 26: The battle over biologic drugs in the country has taken an interesting turn following the latest interim order from the Delhi High Court involving ...
 Business Line3 days ago Mylan appeals court’s interim order on Roche breast cancer drug  Business Line2 days ago Mylan appeals court's interim order on Roche breast cancer drug  FirstWord Pharma2 days ago

New Valeant CEO Papa Trades Challenge at Perrigo for Fresh One

Papa tested in bruising fight against Mylan's hostile takeover Valeant remains embroiled in investigations, sales questions Joe Papa has seen the ups and down of the drug industry firsthand. But he's never run anything quite like Valeant ...
 Bloomberg4 days ago Critics Believe New Valeant CEO Jumped from One Troubled Drugmaker to Another  BioSpace3 days ago
Times of India

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market 2015-2019

1 of 5 FEATURED COMPANIES Acacia Pharma Baxter Healthcare F.Hoffmann La Roche Heron Therapeutics Mylan Pharmaceuticals Otsuka Pharmaceutical MORE About CINV CINV is one of the most dreaded adverse effects of chemotherapy. It often ...
 Research and Markets1 day ago India is a key operations site for Mylan: Rajiv Malik  India Infoline5 days ago India makes all our HIV drugs for developing world: Mylan  Times of India1 week ago One-on-One , 'India makes all Mylan HIV drugs for developing world'  Times of India1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
Get updated on latest news & your favorite topics right in your inbox!
More     Less